Cargando…
Montelukast and Nightmares: Further Characterisation Using Data from VigiBase
INTRODUCTION: Montelukast is a medicine indicated for use in asthma. Psychiatric disorders including nightmares have not been described in clinical trials but during recent years have been included in the product information as having been reported post-marketing, without further description of the...
Autores principales: | Watson, Sarah, Kaminsky, Elenor, Taavola, Henric, Attalla, Marian, Yue, Qun-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189082/ https://www.ncbi.nlm.nih.gov/pubmed/35650509 http://dx.doi.org/10.1007/s40264-022-01183-2 |
Ejemplares similares
-
Characterization of VigiBase reports on tinnitus associated with bisoprolol—An exploratory and descriptive study
por: Watson, Sarah, et al.
Publicado: (2021) -
VigiAccess: Promoting public access to VigiBase
por: Shankar, Pathiyil Ravi
Publicado: (2016) -
Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports
por: Wakao, Rika, et al.
Publicado: (2019) -
Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
por: Sandberg, Lovisa, et al.
Publicado: (2020) -
Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre
por: Watson, Sarah, et al.
Publicado: (2017)